During the past decade, University of Virginia - Acute Care Surgery conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Virginia - Acute Care Surgery" are "COVID-19" (4 trials). Many other conditions were trialed in "University of Virginia - Acute Care Surgery" in a lesser frequency.

Most popular intervention types in "University of Virginia - Acute Care Surgery" are "Drug" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Remdesivir" (4 trials), "Baricitinib" (2 trials), "Dexamethasone" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia - Acute Care Surgery" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University of Virginia - Acute Care Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Virginia - Acute Care Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia - Acute Care Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".